Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2014, Article ID 931808, 9 pages
http://dx.doi.org/10.1155/2014/931808
Clinical Study

Heterogeneity of Radiological Spectrum in Tacrolimus-Associated Encephalopathy after Lung Transplantation

1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Chongqing 400016, China
2Stroke Unit and Department of Vascular Neurology, University Hospital of Strasbourg, 67000 Strasbourg, France
3Department of Pulmonology, University Hospital of Strasbourg, 67000 Strasbourg, France

Received 1 February 2014; Accepted 17 April 2014; Published 27 May 2014

Academic Editor: Rik Vandenberghe

Copyright © 2014 Qisi Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Veroux, M. Veroux, C. Puliatti et al., “Tacrolimus-induced neurotoxicity in kidney transplant recipients,” Transplantation Proceedings, vol. 34, no. 8, pp. 3188–3190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Hodnett, J. Coyle, K. O'Regan, M. M. Maher, and N. Fanning, “PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy,” Emergency Radiology, vol. 16, no. 6, pp. 493–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. O. Bechstein, “Neurotoxicity of calcineurin inhibitors: impact and clinical management,” Transplant International, vol. 13, no. 5, pp. 313–326, 2000. View at Google Scholar · View at Scopus
  4. J. Hinchey, C. Chaves, B. Appignani et al., “A reversible posterior leukoencephalopathy syndrome,” New England Journal of Medicine, vol. 334, no. 8, pp. 494–500, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. S. O. Casey, R. C. Sampaio, E. Michel, and C. L. Truwit, “Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery mr imaging in the detection of cortical and subcortical lesions,” The American Journal of Neuroradiology, vol. 21, no. 7, pp. 1199–1206, 2000. View at Google Scholar · View at Scopus
  6. C. Mueller-Mang, T. Mang, A. Pirker, K. Klein, C. Prchla, and D. Prayer, “Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?” Neuroradiology, vol. 51, no. 6, pp. 373–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. McKinney, J. Short, C. L. Truwit et al., “Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings,” The American Journal of Roentgenology, vol. 189, no. 4, pp. 904–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Y. Donmez, C. Basaran, E. M. Kayahan Ulu, M. Yildirim, and M. Coskun, “MRI features of posterior reversible encephalopathy syndrome in 33 patients,” Journal of Neuroimaging, vol. 20, no. 1, pp. 22–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. S. Bartynski and J. F. Boardman, “Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome,” The American Journal of Neuroradiology, vol. 28, no. 7, pp. 1320–1327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Bargalló, M. Burrel, J. Berenguer, F. Cofan, L. Buñesch, and J. M. Mercader, “Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy,” The American Journal of Neuroradiology, vol. 21, no. 3, pp. 479–484, 2000. View at Google Scholar · View at Scopus
  11. B. Forgacs, H. J. Merhav, J. Lappin, and L. Mieles, “Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation,” Transplantation Proceedings, vol. 37, no. 4, pp. 1912–1914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Sierra-Hidalgo, A. Martínez-Salio, S. Moreno-García, E. de Pablo-Fernández, E. Correas-Callero, and J. Ruiz-Morales, “Akinetic mutism induced by tacrolimus,” Clinical Neuropharmacology, vol. 32, no. 5, pp. 293–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Lee, B. C. Kim, D. H. Yang et al., “Calcineurin inhibitormediated bilateral hippocampal injury after bone marrow transplantation,” Journal of Neurology, vol. 255, no. 6, pp. 929–931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Higuchi, O. Kimura, T. Furukawa, H. Kinoshita, S. Chujo, and N. Iwai, “FK506 induces the atrophy of enteric ganglia in small bowel transplantation, which can be prevented by the neuropeptide bombesin,” Transplantation Proceedings, vol. 38, no. 6, pp. 1823–1824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Bernstein and S. R. Daviss, “Organic anxiety disorder with symptoms of akathisia in a patient treated with the immunosuppressant FK506,” General Hospital Psychiatry, vol. 14, no. 3, pp. 210–211, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Rifai, G. I. Kirchner, M. J. Bahr et al., “A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation,” Liver Transplantation, vol. 12, no. 3, pp. 411–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Wong, G. Z. Beguelin, M. de Lima et al., “Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation,” The British Journal of Haematology, vol. 122, no. 1, pp. 128–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Doelken, S. Lanz, J. Rennert, S. Alibek, G. Richter, and A. Doerfler, “Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI,” Diagnostic and Interventional Radiology, vol. 13, no. 3, pp. 125–128, 2007. View at Google Scholar · View at Scopus
  19. V. Finocchi, A. Bozzao, M. Bonamini et al., “Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature,” Archives of Gynecology and Obstetrics, vol. 271, no. 1, pp. 79–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. O. Lövblad, S. G. Wetzel, T. Somon et al., “Diffusion-weigted MRI in cortical ischaemia,” Neuroradiology, vol. 46, no. 3, pp. 175–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. McKinney, M. Teksam, R. Felice et al., “Diffusion-weighted imaging in the setting of diffuse cortical laminar necrosis and hypoxic-ischemic encephalopathy,” The American Journal of Neuroradiology, vol. 25, no. 10, pp. 1659–1665, 2004. View at Google Scholar · View at Scopus
  22. K. J. Ahn, J. W. Lee, S. T. Hahn et al., “Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity,” The British Journal of Radiology, vol. 76, no. 912, pp. 916–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Shimono, Y. Miki, H. Toyoda et al., “MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients,” European Radiology, vol. 13, no. 5, pp. 986–993, 2003. View at Google Scholar · View at Scopus
  24. A. El Quessar, J. C. Meunier, C. Delmaire, G. Soto Ares, and J. P. Pruvo, “MRI demonstration of cortical laminar necrosis,” Journal de Radiologie, vol. 80, no. 9, pp. 913–916, 1999. View at Google Scholar · View at Scopus
  25. M. Komiyama, H. Nakajima, M. Nishikawa, and T. Yasui, “Serial MR observation of cortical laminar necrosis caused by brain infarction,” Neuroradiology, vol. 40, no. 12, pp. 771–777, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Siskas, A. Lefkopoulos, I. Ioannidis, A. Charitandi, and A. S. Dimitriadis, “Cortical laminar necrosis in brain infarcts: serial MRI,” Neuroradiology, vol. 45, no. 5, pp. 283–288, 2003. View at Google Scholar · View at Scopus
  27. S. Takahashi, S. Higano, K. Ishii et al., “Hypoxic brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging,” Radiology, vol. 189, no. 2, pp. 449–456, 1993. View at Google Scholar · View at Scopus
  28. M. Komiyama, M. Nishikawa, and T. Yasui, “Cortical laminar necrosis in brain infarcts: chronological changes on MRI,” Neuroradiology, vol. 39, no. 7, pp. 474–479, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Renard and G. Taieb, “Cortical susceptibility-weighted imaging hypointensity after stroke-like episode in MELAS,” Journal of Neurology, Neurosurgery, and Psychiatry, 2013. View at Publisher · View at Google Scholar
  30. H. Ito, K. Mori, and S. Kagami, “Neuroimaging of stroke-like episodes in MELAS,” Brain and Development, vol. 33, no. 4, pp. 283–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Iizuka, F. Sakai, N. Suzuki et al., “Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome,” Neurology, vol. 59, no. 6, pp. 816–824, 2002. View at Google Scholar · View at Scopus
  32. B. Kaminska, I. Figiel, B. Pyrzynska, R. Czajkowski, and G. Mosieniak, “Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation,” The British Journal of Pharmacology, vol. 133, no. 7, pp. 997–1004, 2001. View at Google Scholar · View at Scopus
  33. M. Sharma, J. C. Kupferman, Y. Brosgol et al., “The effects of hypertension on the paediatric brain: a justifiable concern,” The Lancet Neurology, vol. 9, no. 9, pp. 933–940, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Servillo, F. Bifulco, E. de Robertis et al., “Posterior reversible encephalopathy syndrome in intensive care medicine,” Intensive Care Medicine, vol. 33, no. 2, pp. 230–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Yamada, R. Kitagawa, and A. Teramoto, “A case of reversible posterior leukoencephalopathy syndrome with acute hypotension,” Neurological Sciences, vol. 32, no. 1, pp. 165–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kochi, H. Takanaga, H. Matsuo et al., “Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus,” Life Sciences, vol. 66, no. 23, pp. 2255–2260, 2000. View at Google Scholar · View at Scopus
  37. J. T. Lin, S. J. Wang, J. L. Fuh, L. T. Hsiao, J. F. Lirng, and P. M. Chen, “Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy,” The American Journal of Neuroradiology, vol. 24, no. 1, pp. 102–104, 2003. View at Google Scholar · View at Scopus
  38. R. Khatri, A. M. McKinney, B. Swenson, and V. Janardhan, “Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke,” Neurology, vol. 79, no. 13, supplement 1, pp. S52–S57, 2012. View at Publisher · View at Google Scholar
  39. V. H. Lee, E. F. M. Wijdicks, E. M. Manno, and A. A. Rabinstein, “Clinical spectrum of reversible posterior leukoencephalopathy syndrome,” Archives of Neurology, vol. 65, no. 2, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at Scopus